Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Rituximab 375, Hodgkin Lymphoma, Cycle 1-4

Protocol-ID: 2360 V1.0 (Mini), RITU375, Hodgkin, C1-4

Indication(s)

  • Hodgkin Lymphoma (Nodular lymphocyte-predominant (NLPHL)); ICD-10 C81.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 11.06.2023